Bellevue Asset Management’s Avanos Medical AVNS Stock Holding History

Bellevue Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.72K	Buy	+69	New	+$1.61K	﹤0.01%	486
2024 Q1	–	Sell	-50	Closed	-$1.12K	–	458
2023 Q4	$1.12K	Hold	50	–	–	﹤0.01%	452
2023 Q3	$1.01K	Hold	50	–	–	﹤0.01%	448
2023 Q2	$1.28K	Hold	50	–	–	﹤0.01%	453
2023 Q1	$1.49K	Hold	50	–	–	﹤0.01%	454
2022 Q4	$1.35K	Hold	50	–	–	﹤0.01%	453
2022 Q3	$1K	Hold	50	–	–	﹤0.01%	458
2022 Q2	$1K	Hold	50	–	–	﹤0.01%	463
2022 Q1	$2K	Hold	50	–	–	﹤0.01%	438
2021 Q4	$2K	Hold	50	–	–	﹤0.01%	477
2021 Q3	$2K	Hold	50	–	–	﹤0.01%	502
2021 Q2	$2K	Hold	50	–	–	﹤0.01%	503
2021 Q1	$2K	Hold	50	–	–	﹤0.01%	553
2020 Q4	$2K	Hold	50	–	–	﹤0.01%	572
2020 Q3	$2K	Hold	50	–	–	﹤0.01%	528
2020 Q2	$1K	Hold	50	–	–	﹤0.01%	581
2020 Q1	$2K	Hold	50	–	–	﹤0.01%	491
2019 Q4	$2K	Buy	+50	New	+$1.81K	﹤0.01%	421

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Bellevue Asset Management's AVNS Position: Q2 2026 in Review

Bellevue Asset Management opened a new position in Avanos Medical (AVNS) in Q2 2026: 69 shares worth $1.72K. The stake represents ﹤0.01% of the portfolio and ranks #486 among its holdings. This is a return to the name: Bellevue Asset Management previously reported a position in AVNS as recently as Q4 2023.

Bellevue Asset Management first reported a position in AVNS in Q4 2019 and has held it in 18 quarters since. The position peaked at $2K in Q1 2022. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Bellevue Asset Management held 69 shares of Avanos Medical worth $1.72K as of Q2 2026.
Avanos Medical was a new Bellevue Asset Management position in Q2 2026.
Avanos Medical made up ﹤0.01% of Bellevue Asset Management's portfolio in Q2 2026, its #486 holding.
Bellevue Asset Management first reported a position in Avanos Medical in Q4 2019 and has held it in 18 quarters since.
Bellevue Asset Management's Avanos Medical position peaked at $2K in Q1 2022.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Bellevue Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.